MiR-4510 inhibited the growth of HCC-derived Huh7 and Hep3B cells and of HBL-derived Huh6 cells (which carry a missense G34V mutation in β-catenin/CTNNB1 gene) and it was significantly more effective than miR-34a-5p in Hep3B cells (Figure 6A). This evidence concerns the gene CTNNB1 and hepatocellular carcinoma.